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Abstract
The purpose of this study was to determine whether primary care providers 
(PCPs) in Mississippi are following the selected Centers for Disease Control and 
Prevention (CDC) guidelines published in March 2016 for prescribing opioids for 
chronic, non-cancer pain. The study also sought to determine if the selected providers 
prescribed naloxone for opioid overdose reversal. Drug overdoses have increased 
exponentially in the last 3 decades in the United States (Doyon, Aks, & Schaeffer, 2014) 
— leading to opioid overdose becoming the most frequent cause of accidental death. 
Opioid overdose death rates are so high the CDC declared it a problem of “epidemic” 
status in 2012 (Canada, DiRocco, & Day, 2014).
Mississippi ranks as one of the highest prescribing states for opioid analgesics.
For the purpose of this research, focus was placed on specific aspects o f the CDC 
guidelines as follows: (a) consider nonpharmacological treatment or treat with nonopioids
first, (b) avoid prescribing opioids and benzodiazepines concurrently, and (c) check a 
urine drug screen prior to opioid initiation and yearly thereafter (CDC, 2016). The CDC 
now recommends prescribing naloxone, an opioid antagonist, to patients at risk for opioid 
overdose. Naloxone has demonstrated effectiveness in reducing opioid overdose 
mortality.
A nonexperimental, quantitative, descriptive, retrospective review of charts was 
performed in 6 primary care clinics in Mississippi staffed by physicians and family nurse 
practitioners. A convenience sampling of 600 charts for retrospective chart review was 
conducted. Inclusion criteria were age 18 years or older, medically treated long-term 
with opioids (> 2 prescriptions written >21 days apart) for chronic non-cancer pain, and 
prescribed by a PCP.
The findings suggested that PCPs in Mississippi are not eonsistently following 
CDC guidelines for opioid prescribing. It should also be noted that, of the 600 charts 
reviewed, none of the patients were prescribed naloxone for reversal of a potential opioid 
overdose. Research demonstrated a need for increased awareness and education among 
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Dimensions of the Problem
Drug overdoses have increased exponentially in the last three decades in the 
United States (Doyon, Aks, & Schaeffer, 2014). More alarmingly, the leading cause of 
accidental death in the United States (U.S.) is overdose, specifically opioid overdose. 
Because opioid overdose death rates are so high, the Centers for Disease Control (CDC) 
declared this drug a problem of “epidemic” status in 2012 (Canada, DiRocco, & Day, 
2014). In 2013, over 43,000 deaths were reportedly due to drug overdose in the U.S. 
Fifty-six percent were opioid-related deaths; of these, 37% were related to analgesic 
opioid prescription drugs (Wheeler, Jones, Gilbert, & Davidson, 2015). Prescription 
opioids account for the greatest negative effects associated with prescription misuse.
Mississippi ranks as one of the highest prescribing states for opioid analgesics 
where most pain medications prescribed are written by primary care providers and 
dentists. As of July 2016, hydrocodone is the most prescribed controlled substance in 
Mississippi, followed by alprazolam and oxycodone. These alarming statistics spotlight 
a major area of concern in our state for primary care providers (Mississippi State 
Department of Health, 2012)
Opioids can produce effects of pleasure where patients may intentionally abuse 
to seek self-gratification. This addiction is a serious problem that affects the health and 
social welfare of our society. Risk factors for overdose include receipt of more than 50 
mg morphine equivalents, concurrent benzodiazepine use, or substance use disorder as 
reported by the American Medical Association, the Medical Board of California, and 
the Centers for Disease Control (CDC) (Behar, Rowe, Santos, Murphy, & Coffin,
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2016). Due to growing concern over opioid misuse and overdose, recent guidelines 
have been published by the CDC to assist providers in safely prescribing these drugs. 
For the purpose of this research, focus was placed on specific aspects o f these 
guidelines as follows;
1. Consider nonpharmacologic treatment or treat with nonopioids first.
2. Avoid prescribing opioids and benzodiazepines concurrently.
3. Check a urine drug screen prior to opioid initiation and yearly thereafter 
(CDC, 2016).
Recently, recommendations have been made to prescribe naloxone, an opioid 
antagonist, to patients at risk for opioid overdose. Reductions in opioid overdose 
mortality have been associated with the increased distribution of naloxone. As of 
August 2016, all states in the U.S. allow physicians and practitioners to prescribe 
naloxone to laypersons. Despite having the ability to prescribe naloxone, limited data 
exist suggesting that primary care providers are seeking recommendations to preseribe 
naloxone (Behar et al., 2016). Naloxone is a life-saving treatment that has increasingly 
been prescribed by some providers as an opioid reversal agent. Prescription naloxone 
has reversed more than 10,000 overdose cases between 1996 and 2010 according to the 
CDC (2016). However, rural communities have underutilization to many addiction 
treatment facilities which commonly offer naloxone. A study by Behar et al. (2016) 
found that when naloxone is prescribed by primary care providers the distribution is 
higher than with community distribution alone. Behar et al.’s (2016) statistical 
findings regarding naloxone were alarming and are as follows: 87% of patients reported 
they were prescribed opioids for pain, 53% reported taking opioids in a manner other
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than as prescribed, 37% reported seeking medical treatment for overdose, 53% reported 
witnessing an overdose, and 27% reported being administered naloxone. Furthermore, 
90% of patients had never received naloxone, 60% had never heard of it before the 
intervention, and 82% filled the prescription. These findings demonstrate that naloxone 
is drastically underutilized as a lifesaving reversal agent. (Behar et al., 2016)
Factors such as patient safety and addiction rates are primary concerns of 
prescribers. These concerns are justifiable as the misuse of prescription opioids is a 
major problem in the U.S. Incorporating screening and opioid education may be the 
first step by primary care providers in the prevention of opioid drug abuse. Providers 
may need to initiate a screening tool that highlights risk of misuse, especially for those 
prescribed opioids for chronic pain. Additionally, opioid education should be a key 
element of chronic non-cancer pain treatment modalities. The opioid overdose 
epidemic, whether intentional or accidental, continues to rise.
For the purpose of this research, focus was placed on the following: (a) 
adherence in Mississippi to select CDC guidelines for opioids; (b) prescribing 
frequency of naloxone by primary care providers; and (e) opioid education among 
chronic, non-cancer pain patients. Focus on these key areas may highlight areas with 
needed improvement in regard to Mississippi’s opioid prescribing practices.
Purpose of the Research Project
The purpose of this study was to determine whether primary care providers in 
Mississippi are following the selected CDC guidelines, as outlined through questions 
posed by the current researchers for prescribing opioids and whether those providers 
prescribed naloxone for opioid overdose reversal. The selected questions follow the
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treatment progression recommended by the CDC in regard to chronic, non-cancer pain 
treatment which is outlined as follows: nonpharmacologic therapy, nonopioid therapy, 
and obtaining a urine drug screen prior to initiating opioid therapy and then annually. It 
is also recommended to avoid concurrent benzodiazepine and opioid prescriptions. 
Furthermore, the current researchers determined whether naloxone was being prescribed 
and whether education regarding opioid risks and opioid reversal was provided. 
Significance of the Research Project
Overdose deaths due to opioids were recognized as an epidemic in 2012 (Doyon 
et al., 2012). Drug overdose-related deaths have surpassed deaths related to motor 
vehicle crashes. Now, deaths due to opioid overdose have exceeded the combined total 
deaths due to heroin and cocaine overdose (Center for Mississippi Health Policy, 2013). 
Healthcare providers lacked a general consensus on treatment o f chronic, non-cancer 
pain prior to the release of the CDC’s latest guidelines. This research project was 
designed to determine if prescribers in a defined region are adhering to the guidelines 
set forth by the CDC.
Future researchers can utilize results from this research to assess the urgency for 
further dissemination of education among practitioners regarding opioid prescribing 
practices in Mississippi. The results of this research identified the need for all 
healthcare providers, including nurse practitioners, to follow the selected CDC 
guidelines and provide patient education regarding opioid use. The lack of patient 
education regarding the side effects of opioids leads to misuse— oftentimes resulting in 
lethal overdose. In addition to patient education, provider education regarding 
appropriate chronic, non-cancer pain management aides healthcare providers in
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increasing compliance and safety. This research also identified whether or not 
providers are prescribing naloxone for opioid overdose. Prescribing naloxone could be 
a significant component to caring for patients suffering from opioid addiction.
Research regarding prescription naloxone is significant because naloxone has been 
shown to decrease deaths related to opioid overdose.
The information obtained through this research demonstrates implications to all 
healthcare providers, including nurse practitioners. Primary care providers need to be 
prepared to provide proper treatment to these patients by being aware of the CDC 
prescribing guidelines so that patients are not inappropriately prescribed opioids. Also, 
nurse practitioners need to be aware of naloxone for opioid overdose so they can make 
an informed decision about prescribing or not prescribing naloxone.
Another component of prescribing opioids which holds significance 
predominantly to nurse practitioners in the primary care setting is education about 
opioid use. Nurse practitioners need to realize the impact they have on their patients 
when prescribing opioids. Each clinic visit is an opportunity for practitioners to educate 
patients about opioid use and misuse. Patients need to understand that improper use can 
be lethal. When nurse practitioners enforce the selected CDC prescribing guidelines, 
consider naloxone for opioid overdose and provide patient education. Enforcement of 
these guidelines could decrease the likelihood of negative outcomes due to opioid 
overdose.
Conceptual Framework
The theory proposed by Nola J. Pender, PhD, RN, FAAN, is entitled the Flealth 
Promotion Model (HPM). The HPM was the theoretical foundation for this body of
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work. This model reflects a holistic view of nursing in which providers see patients as 
people who are responsible for their health and wellness. One significant goal of this 
research was to expound the relevance of the HPM for opioid prescribing practices in 
Mississippi.
To better understand the HPM and the application of the model to practice, 
Pender defined many major concepts and definitions. These concepts and definitions 
have expanded over the years; therefore, they are even more relevant to the promotion 
of healthy lifestyles. The HPM consists of the following major concepts: individual 
characteristics and experiences, behavior-specific cognitions and affect, and behavioral 
outcome (Alligood, 2014). Providers use each of these concepts to predict how a 
patient might respond during certain behavioral situations. The following discussion of 
a research article review provides further explanation of the concepts and definitions of 
Pender’s theory applied in practice.
In the research, Nola Pender highlighted patient behavioral responses when 
counseled on the importance of physical activity. According to Eden, Orleans, Mulrow, 
Pender, and Teutsch (2002), the findings revealed that most patients struggle to 
maintain exercise goals. Eden et al. (2002) related the struggles to factors, such as 
differences in activity levels at the baseline and decreased provider intervention. 
Utilizing Pender’s model in this study allowed the researchers to analyze the motive for 
physical inactivity.
Eden et al. (2002) first examined the individual characteristics and experiences 
of the population under study. These characteristics and experiences included sedentary 
lifestyles and minimal healthy habits. The behavior speeific cognitions and affect
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during the first part of the study revealed many barriers to action due to low self- 
efficacy (Eden et ah, 2002). There were no specific interpersonal or situational 
influences listed. Due to the increased level of barriers to action (i.e., overweight, out 
of shape, and sedentary), the patients’ perceived benefits of action did not result in 
health-promoting behaviors. However, after input and counsel from providers, the 
patients’ behavior specific cognitions and affect changed. The outcome was health- 
promoting behaviors (Eden et al., 2002). The application of the HPM in this research 
mirrors how the current researchers applied the HPM to chronic pain patients.
As previously mentioned, the purpose this research was to explore opioid- 
prescribing practices in Mississippi and the use of naloxone for opioid overdose 
reversal. The HPM was used in this study to explore practitioners’ tendencies to 
encourage health-promoting lifestyles to chronic pain patients. The HPM also was used 
as a guideline to assess positive or negative behavioral outeomes of opioid prescription 
to chronic pain patients.
The guidelines for opioid-prescribing set forth by the CDC can also be 
incorporated into the HPM. These recommendations served as a beneficial guide to this 
research project relating to chronic opioid use. Nola Pender’s HPM predicts patients’ 
tendencies on how everyone will participate in the behaviors that improve health. 
Pender’s model has contributed to health promotion and has provided practitioners the 
framework to motivate patients to attain a state of well-being. The CDC guidelines also 
assist practitioners and other medical professionals with the appropriate measures 
necessary for monitoring the safety of individuals with chronic opioid use. Data
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pertinent to this research can be hypothesized with the use of such guidelines; therefore, 
information can be examined for the continuum of research on this topic.
Research Questions
Health promotion is important in motivating patients with chronic pain to attain 
a healthier lifestyle by avoiding misuse of opioids. The purpose of this study was to 
explore whether primary eare providers were following guidelines for prescribing 
opioids, prescribing naloxone as an opioid reversal agent, and providing sufficient 
education to patients prescribed opioids. The following research questions addressed 
each topic:
1. Are primary care providers in Mississippi compliant with the following 
selection of the CDC’s latest guidelines for prescribing opioids for chronic 
pain?
a. Nonpharmacologic therapy or nonopioid pharmacologic therapy first.
b. Avoid concurrent prescribing of opioids and benzodiazepines.
c. Check urine drug screen prior to opioid initiation and then annually.
2. Are primary care providers in Mississippi prescribing naloxone for opioid 
overdose reversal?




For the purpose of this study, the following terms were defined with both 
theoretical and operational definitions. The theoretical definitions are concrete and 
broad. The operational definitions are abstract and define the utilization of terminology 
as it pertains to this research project.
Primary care providers (PCP)
Theoretical: The healthcare provider (i.e., the nurse practitioner, physician’s 
assistant, or physician) to whom a patient first goes to address a problem with his or her 
health (Venes, 2013).
Operational: A healthcare provider who sees people that have common medical 
problems. This person may be physician, physician assistant, or a nurse practitioner.
Centers for Disease Control and Prevention (CDC) guidelines
Theoretical: A set o f current and relevant guidelines published by a division of 
the U.S. Public Health Service headquartered in Atlanta, Georgia, that investigates and 
controls various diseases, especially those that have epidemic potential. The agency is 
also responsible for national programs to improve laboratory conditions and encourage 
health and safety (Venes, 2013).
Operational: A set of guidelines published by the CDC which offers 
recommendations for prescribing practices regarding the management of chronic, non­
cancer pain. Specifically, the CDC recommends that prescribers follow the treatment
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progression as follows: nonpharmacologic therapy, nonopioid therapy, and obtain drug 
screen initially and then annually before prescribing opioids.
Opioids
Theoretical: Any synthetic narcotic not derived from opium (Venes, 2013). 
Operational: A synthetic drug designed to mimic the effects of opium or 
opiates; a narcotic prescribed by primary care providers to patients in this study. 
Chronic pain
Theoretical: Long-lasting discomfort, with episodic exacerbations. Pain that 
lasts more than 3 months. Pain that lasts more than a month longer than the usual or 
expected course of illness or injury (Venes, 2013).
Operational: Pain lasting longer than 12 weeks or longer than normal tissue
healing.
Non pharmacologic therapy
Theoretical: Any therapy prescribed or recommended to improve health or 
wellness—not related to the use of drugs (Laurence, 2010).
Operational: Any therapy used to treat pain, excluding pharmaceutical drugs; 
including, but not limited to, cognitive behavioral therapy, physical therapy, exercise 
therapy, weight loss, biopsychosocial therapy, multimodal pain therapy, and 
interventional therapy.
Nonopioid pharmacologic therapy
Theoretical: The use of any medicinal treatment to reduce pain, with the 
exception of drugs falling within the chemical classification of opioids.
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Operational: A drug therapy used to treat pain, excluding the opioid class of 
drugs; including, but not limited to, acetaminophen, nonsteroidal anti-inflammatory 
drugs, anticonvulsants, and antidepressants.
Concurrent prescribing (opioids and benzodiazepines)
Theoretical: Happening at the same time; simultaneous writing, or 
administering, of medications such as opioids and benzodiazepines.
Operational: Writing or administering opioids with benzodiazepines which is 
contraindicated by the latest CDC guidelines.
Benzodiazepines
Theoretical: Any group of chemically similar psychotropic drugs with potent 
hypnotic and sedative action; used predominantly as antianxiety and sleep-inducing 
drugs (Venes, 2013).
Operational: A class of drugs that can be harmful if taken in excessive amounts.
Urine drug screen
Theoretical: A test used to detect illegal and some prescription drugs in the 
urine including opioids and benzodiazepines.
Operational: Testing performed prior to prescribing of opioids to establish 
current social and medical habits and repeated periodically throughout care to confirm 
proper administration and avoid concurrent use with other drugs prescribed or illegal.
Naloxone
Theoretical: A drug that is antagonistic to the actions of narcotics and opiates, 
such as morphine, methadone, and opium. It is helpful in reversing the respiratory 
depression caused by an overdose of narcotics (Venes, 2013).
23
Operational: A drug prescribed by primary care providers in an outpatient 
setting to reverse the effects of opioid overdose.
Overdose
Theoretical: An excessive and potentially toxic amount of a medication given in 
error or taken intentionally (Venes, 2013).
Operational: An excessive or toxic amount of opioid ingestion requiring 
administration of the reversal agent—naloxone.
Education
Theoretical: Health information and instruction to help patients leam about 
specific or general medical topics, such as preventive services, the adoption of healthy 
lifestyles, the correct use of medications, or the care of diseases or injuries at home 
(Venes, 2013).
Operational: Information given to a patient regarding proper usage of opioids 
and the risks associated with opioids, such as central nervous system depression that 
could lead to respiratory depression or arrest. Education should also include risk of 
dependence as well as avoidance of alcohol and other sedatives.
Patient(s)
Theoretical: One who is sick with, or being treated for, an illness or injury 
(Venes, 2013).
Operational: One who is 18 years of age or older and is currently being treated 
for ehronic pain with the use of opioid pain medication.
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Assumptions
Assumptions in this study included the following:
1. Adherence to CDC guidelines by primary care providers in regard to opioid- 
prescribing practices will reduce the risk o f opioid related overdose and 
opioid misuse.
2. Naloxone prescription may prevent a fatal overdose secondary to opioid 
overdose but may increase risky behavior in patients presenting with chronic 
pain.
3. Patients presenting to the clinic with complaints of acute pain were being 
screened for chronic pain.
4. Primary care providers in Mississippi are following the latest CDC guidelines 
when prescribing opioids.
The current researchers assumed that the data required to perform this research 
would be available upon the review of the charts and data would be organized and 
comprehensible. It was assumed that data would be collected in a legal and ethical 





The purpose of this study was to determine whether primary care providers were 
following GDC guidelines for prescribing opioids and whether these providers were 
prescribing naloxone for opioid overdose reversal. Drug overdoses have increased over 
the last three decades in the U.S., and Mississippi ranks as one of the highest states for 
prescribing opioids. The most frequent opioids prescribed, according to the Mississippi 
State Department of Health in 2012, are hydrocodone and oxycodone. Prescription 
opioid abuse leads to unintended overdoses and ultimately can result in death. These 
overdoses are related to patients’ behavioral experiences regarding opioid use.
To expand knowledge of opioid overdoses and providers’ prescribing habits, 
this research group reviewed numerous research articles. This chapter will present the 
conceptual framework and related literature through various research articles. The 
framework for this study and the literature review were used as evidence promoting the 
need for stricter compliance of CDC-prescribing guidelines and improved education for 
patients regarding opioid overdose. The literature review also highlighted the 
importance of prescription naloxone for opioid overdoses.
Conceptual Framework
In determining a conceptual framework for this research, the student researchers 
reviewed several studies which utilized Pender’s HPM as the theoretical basis. One 
study which employed Pender’s HPM was conducted by Conway, McClune, and Nosel 
(2007). The study focused on a significant problem in the U.S. regarding children’s 
safety and the agriculture industry. Agriculture surpasses all others by measure of
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dangerous workplaces, with an accidental work-related death rate six times greater than 
all other industries combined (Conway et al., 2007). In 1999, the National Agricultural 
Statistics Service (NASS) reported there were over 2 million farms nationwide. On 
these farms, 1.5 million children lived and/or worked. Reportedly, over 100,000 
injuries occur annually in children while on farms. O f these, 100 children die each year.
Conway et al. (2007) conducted this pilot study to examine farm safety 
education for families and children provided by healthcare professionals. The 
researchers used Pender’s model to depict how primary care providers (PCPs) promote 
healthy behaviors in their practice regarding farm safety education. Furthermore, the 
study was threefold in purpose: (a) quantify the number of farm accidents through PCPs 
healthcare records, (b) determine barriers to safety equipment or protocol, and (c) 
determine the rate at which PCPs provide education regarding farm safety. The 
conceptual framework for the study was based on Pender’s HPM. The researchers 
discussed one of Pender’s major assumptions that individuals are constantly 
transforming their surroundings, while at the same time their surroundings are 
constantly transforming the individual. Conway et al. (2007) stated that, “The 
individual variable of perceived benefits of action, personal barriers of action, perceived 
self-efficacy, activity-related effects, situational influences, and interpersonal influences 
can be modified to increase health-promoting behaviors” (p. 45).
The method utilized was a survey that focused on farm safety issues confronted 
by PCPs. Included in the survey were demographics, documented farm injuries, and 
PCPs’ knowledge of farm safety educational materials. A panel of experts reviewed the 
content for validity. A convenienee sample of 110 PCPs was used from 5 separate
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northwestern Pennsylvania counties. The surveys were sent out via mail to be returned 
anonymously with prepaid return envelopes; follow-up reminders were sent at 2 weeks 
to increase response rates. There was a low return of 22 surveys.
The returned surveys included PCPs as the participants. These PCPs were 
medical, osteopathic, and chiropractic physicians; physician’s assistants; and nurse 
practitioners. Injuries reported included lacerations, animal injuries, muscle strains, 
machinery/equipment injury, and one fatality. One child was mauled by an animal and 
required surgery. Forty-five percent of PCP’s reported that their initial assessments 
included questioning new patients if children lived or worked on a farm. Eighteen 
percent (18%) of PCPs reported performing specific education on farm injury 
prevention. Only 5% had related handouts available for distribution; however, 73% 
voiced interest in attaining farm injury prevention materials.
The results of Conway et al.’s (2007) study found that additional education is 
recommended to promote safer farm environments for children. A limitation of the 
study would be generalization. A continuation of the pilot study would be required for 
validation using a larger population. Potentially, a continuation study could provide 
data to ensure health-promoting resources to decrease farm-related injuries and death.
Agazio and Buckley (2010) conducted a study to explore women’s health 
promotion behaviors in the U.S. military. In this study, the researchers used a 
descriptive correlational design. Their conceptual framework was based on Pender’s 
HPM, specifically two categories of factors: personal factors and behavior-specific 
cognitions. The purpose of the study was to differentiate between causative factors for 
health-promoting behaviors. Personal factors were defined as demographic
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characteristics, perceived health status, and definition of health (Agazio & Buckley, 
2010) while behavior-specific cognitions were defined as perceived self-efficacy and 
interpersonal influences (Agazio & Buckley, 2010).
The research questions focused on these personal factors and behavior-specific 
cognitions and their correlation to demographics, interpretations of health, self-worth, 
and resources. Another research objective was to decipher the differences among 
healthy behaviors in differing groups of military women. Agazio and Buckley (2010) 
believed that with more women involved in the military, there was a growing burden of 
balancing work and family responsibilities. Agazio and Buckley predicted that this, in 
turn, affected health-promoting behaviors. The population sample was comprised of 
491 military women and included active duty, reservists, childbearing, and non­
childbearing individuals. The participants were recruited from 2 military hospitals and 
enrolled voluntarily via phone or email. Up to 150 participants were included in each 
group. If a participant volunteered, a study packet was sent with a stamped envelope to 
the participant. Included in the packet was a study instrument with instructions to 
complete and return in the stamped envelope. The study instrument included 2 of 
Pender’s resources, the Perceived Health Status (Pender, Walker, Frank-Stromborg, & 
Sechrist, 1990) and the Health-Promoting Lifestyle Profile II (HPLP-II) (Pender et al., 
1990); other instruments were included in the packet (Agazio & Buckley, 2010).
The instruments attained quantitative measurement of each of Pender’s HPM 
variables and utilized several Likert-rating scales. Descriptive statistics were used and 
determined statistical significance of the data. Pearson correlation coefficients were 
also used to interpret the research findings. The research concluded that 59% of
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participants were on active duty and 51.2% had children. The average age of 
participants was 37.2 years. Surprisingly, the most significant finding was the 
comparison between active duty women with children (ADWWC) and all other 
categories. ADWWC scored significantly higher for all health-promoting behaviors 
which was not the anticipated outcome based on previous research by Agazio and 
Buckley (2010). The researchers explained the findings, assuming ADWWC high 
scores were due to time management skills, improved organization, and increased 
awareness and commitment to personal wellness. The researchers suggested these 
attributes may have been acquired during motherhood due to role modeling and 
conscious efforts towards building healthy behaviors in children. Other findings were 
that all groups scored the highest in spiritual growth. Accordingly, all groups scored the 
lowest on ability to manage stress.
Agazio and Buckley (2010) concluded that, though the study validated Pender’s 
model of behavior-specific cognitions (perceived self-efficacy and interpersonal 
resources), none of the personal characteristics (age, marital status, ethnicity, health 
conception scale, and personal health status) were determined to be significant 
indicators of health promotion amongst the groups. Limitations to the study could have 
consisted of higher proportion of Caucasians, sample age median of 37 years, 
recruitment site for participants, and possible lack of causative factors not identified in 
the study. The variance could have been explained in more detail had the researchers 
identified situational influences, barriers to health, and benefits of health promotion 
from Pender’s most recent HPM. Another possible limitation was that there are factors 
unique to military women that have not yet been determined.
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The implication of this body of research by Agazio and Buckley (2010) was that 
self-efficacy is highly predictive of successful health-promoting behaviors. Therefore, 
future healthcare interventions might include assisting in personal success recall 
strategies, assisting with achievable goal-setting, and sharing of successful strategies 
used by other women. The study also implicated that self-efficacy did not suffice on its 
own; instead, tangible support proved to be necessary to implement goal-reaching 
strategies. Interventions for this factor could be achieved at the organizational level by 
improving policies relating to extended hours for childcare, flexible work hours, family- 
friendly work environments, worksite health promotion programs, on-site health 
facilities, and respecting non-work hours. Pender’s HPM guided the entire body of 
research. Each individual aspect of the study was based on Pender’s model (Agazio & 
Buckley, 2010).
In conclusion, Pender’s HPM was a solid model from which the student 
researchers based their work. Its holistic approach was applied to the current research 
and allowed the student researchers to carefully examine PCPs’ health promotion 
strategies regarding opioid prescribing.
Review of Related Research
Review of research studies validated the necessity of the research topic of the 
student researchers. These research studies highlighted the importance of primary care 
providers’ compliance to opioid prescription guidelines as well as the need for 
improved patient education regarding the consequences of opioid overdose. These 
studies also revealed providers’ views on naloxone prescription for opioid overdose 
reversal.
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Decision to prescribe opioids. Harle et al. (2015) explored the decision­
making processes of primary care providers for managing patients’ chronic pain with 
opioids. Many providers struggle to provide effective pain management while avoiding 
opioid misuse and abuse. According to the Institute of Medicine, chronic pain is a 
major burden on 100 million Americans annually. A lack of pain specialist physicians 
results in the need for primary care providers to manage chronic pain. Primary care 
providers also report frustration and hindrance in prescribing opioids due to lack of time 
and minimal training in chronic pain management. In this study, Harle et al. sought to 
determine if certain providers failed to use recommended guidelines due to lack of time 
and insufficient knowledge.
Harle et al. (2015) used qualitative interviews to conduct this study. The 
locations were 9 medical facilities in rural and urban settings in the Gainesville and 
Jacksonville areas of north central Florida. The providers, differing in age and 
experience, volunteered for the study and submitted written informed consent. 
Throughout the interviews, the providers discussed clinical information pertinent to 
them when prescribing opioids for chronic pain. After the interviews, the researchers 
identified 5 themes: (a) importance of objective and consistent information, (b) 
identifying red flags, (c) significance of physical function and goals, (d) trust, and (e) 
time constraints.
Each theme enlightened the researchers on the providers’ decisions to prescribe 
or not to prescribe opioids. The first theme highlighted the issue of inconsistency with 
subjective versus objective information. Identifying red flags was an important theme 
because these revealed patients’ tendencies to seek opioid treatment due to addiction.
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The third theme established goals for seeking pain management, and the fourth theme 
addressed a provider’s “sense” of a patient’s need for pain management. The fifth 
theme developed due to providers’ lack of time during clinic visits based on patients’ 
comorbidities as well as chronic pain. After the study, Harle et al. (2015) 
acknowledged the need for future research to develop and disseminate decision support 
tools for prescribing opioids.
Harle et al. (2015) had strengths and weaknesses. Two strengths were 
identified: (a) dissimilarity in age and experience of the providers and (b) differentiation 
in practice specialty, location, and practice ownership. One weakness was the lack of 
transferability of decision-making approaches across different cultures and larger 
international boundaries. Unfortunately, the study also had limitations due to the small 
sample size consisting of providers only from only one state. As a result, the findings 
of Harle et al. (2015) did not reflect feelings and thoughts from provider groups in other 
states. The limitations in the current study may mimic this study’s limitations due to 
sample size and population.
Harle et al. (2015) related to the current research by addressing the issues 
concerning opioid prescribing. While Harle et al. did not address any of the current 
researchers’ research questions specifically, there was still enough information to 
strengthen the researchers’ first question. This study explained that some providers 
have difficulty abiding by such guidelines due to certain barriers. The findings in this 
study strengthened the current researchers’ foundation for the first research question by 
identifying providers’ decision-making processes for prescribing opioids. While the 
current researchers may not directly respond to the challenge for future research, the
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study will strengthen the need for future researchers to disseminate decision support 
tools and to provide education about managing chronic pain.
Opioid crisis and resolution. Wolfe, Bouffard, and Lowe (2016) discussed the 
problem of opioid overdoses. The Centers for Disease Control and Prevention stated 
that too many physicians are prescribing opioids to patients who are in serious pain 
without trying other methods first. Wolfe et al. (2016) wanted to discuss the problem of 
opioid overdoses and provide information on how to reduce the number of deaths from 
opioid overdoses.
The main objective of Wolfe et al. (2016) was focusing on the administering of 
naloxone (Narcan) to stop the effects of the opioid. The CDC labeled the epidemic of 
opioid overdoses in 2012, but the problem has only gotten worse. One reason for the 
growing epidemic is the availability of heroin in the U.S. Another reason is the 
growing number of prescriptions being given to patients for pain. Many of the overdose 
victims did not take the medication as prescribed or obtained the medication from 
someone else to try and eliminate their pain. Wolfe et al. (2016) listed four 
subcategories of prescription medicine: pain relievers, tranquilizers, stimulants 
(including Ritalin), and sedatives. About two thirds of the misused prescriptions were 
gotten from a friend or relative or were stolen. Wolfe et al. (2016) stated that in 2010 
there were “enough prescriptions written annually for painkillers to medicate every 
adult American around the clock for a month” (p. 326). Some people even believe that 
the painkiller is safe because a physician prescribed it.
The population with the highest overdoses is non-Hispanic white males while 
overdoses among women are increasing. West Virginia has the highest overdose rate.
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and North Dakota has the lowest. To reduce these numbers, the CDC recommends that 
the naloxone be administered when an overdose is expected. Many argue that 
prescribing naloxone to reduce the effects of the opioid will only encourage the 
continued use of the opioid. If a person stays off the opioid for 3 or more days, then the 
tolerance that has been built up will be reduced. A smaller amount of the opioid can 
cause an even greater risk because the tolerance level has been reduced.
Wolfe et al. (2016) recommended that naloxone be administered to reduce the 
effects o f an overdose by policemen, emergency responders, and hospital staff. Wolfe 
et al. (2016) stated that anyone who administers the drug should be properly trained. A 
Good Samaritan law was passed that allowed someone to call in a suspected overdose 
victim without being charged with a crime involving drugs. The legislation from 2015 
requires that anyone who might administer naloxone (e.g., physicians, physician 
assistants, advanced practice registered nurses, and dentists) must take a one-hour 
continuing medical education on safe opioid prescribing methods.
Specific guidelines were set forth by the CDC for prescribing opioids. These 
guidelines recommend that a doctor should not start with opioid medication, and 
alternative treatment should be tried first. The CDC also recommends setting a goal for 
how long the opioid should be prescribed. An immediate release opioid should be used 
instead of an extended release form. The lowest possible dose should be given. The 
physician should evaluate the benefits and the harm of the opioid medication. The 
physician should also avoid the opioid prescription if there are risk factors of an 
overdose. A urine test should be taken before prescribing the opioid to determine if the
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patient is on any other drug. Finally, the physician should check the prescription drug 
monitoring system regularly.
Wolfe et al. (2016) was not based on studies that were conducted in a controlled 
environment with set members. Wolfe et al. (2016) presented their beliefs on the use of 
naloxone and discussed the necessity of using the drug for overdose victims to reduce 
the number of deaths. Wolfe et al. (2016) presented the information clearly and 
effectively and explained the steps to be taken in the event of a drug overdose and the 
dosage of naloxone which could be used. Wolfe et al. (2016) believed that physicians 
prescribed opioids too often before trying other methods like exercise, relaxation 
techniques, and others.
These authors were a knowledgeable group of experts who had PhDs or medical 
degrees, and they worked as mental health experts. Wolfe et al. (2016) realized the 
mental associations that could cause an overdose— stress, anger, depression, etc. To 
reduce the number of overdose deaths, Wolfe et al. (2016) encouraged physicians to be 
careful about prescribing opioid medications and encouraged the physicians to try other 
methods of pain relief before prescribing opioids. O f course, Wolfe et al. (2016) did not 
just advocate the use of naloxone, they also recommended treatment programs to reduce 
illegal drug use or misuse involving prescription medicine.
Better approach to opioid prescribing. Canada, DiRocco, and Day (2014) 
conducted a study to evaluate opioid-prescribing practices, providers’ attitudes toward 
competent management of chronic non-cancer pain (CNCP) patients and knowledge 
regarding prescribing opioids. Misuse of prescription opioids is a major problem in the 
U.S., and opioid overdose death rates are so high that the CDC declared it a problem of
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“epidemic” status in 2012. Canada et al. (2014) developed and implemented a new 
electronic medical record-based protocol to improve opioid prescribing practices. This 
protocol included an educational intervention for providers, standardization of 
documentation, and standardization of management of CNCP. The researchers tested 
their protocol and found providers who adhered had higher satisfaction rates with 
management of CNCP patients.
The apparent hypothesis for Canada et al. (2014) was that “a clinical protocol 
for opioid prescribing could improve the care that physicians and staff were providing 
to CNCP patients, as well as improve the satisfaction that clinicians felt in providing 
this care” (Canada et al., 2014, p. 2). An additional stated goal was “to determine 
whether this initiative would result in adherence to the protocol and improve provider 
and staff knowledge and satisfaction with management of patients prescribed opioids 
for CNCP” (Canada et al., 2014, p. 2).
Canada et al. (2014) performed this study within their own clinics (3 internal 
medicine practices) at the University o f Pennsylvania, Division of General Internal 
Medicine. Providers included attending physicians and nurse practitioners. Staff 
members included were registered nurses, licensed practical nurses, medical assistants, 
and patient service representatives. The study took place over one year. During this 
time, the first 3 months consisted of educating the providers and staff, while the 
remaining 9 months was the actual period of evaluation. Pre- and post-surveys were 
conducted but were anonymous. A protocol was developed based on expert opinion 
and best-practice guidelines. The goal was quality improvement. The protocol initiated 
standardization of documentation and management and required urine drug screenings
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(UDS) and Controlled Medication Agreements (CMA). A “smart set” was created to 
streamline and standardize the documentation in the electronic medical record (EMR). 
The protocol, “smart set,” and surveys were developed via monthly meetings of expert 
anesthetists, pain management specialists, and psychiatrists who reviewed the latest 
evidence-based practices and recommendations.
The method for the study by Canada et al. (2014) was comprised of 4 
components: the development o f the protocol, instruction for using the protocol, data 
collection, and a monetary incentive for providers who followed the protocol. Included 
in the study were patients with > 2 opioid prescriptions over 6 months; acute pain 
conditions were excluded. The variables of interest were the different provider roles: 
attending physicians, resident physicians, and nurse practitioners. Patient demographics 
were also a variable.
The study by Canada et al. (2014) was measured by examining the compliance 
levels, pre- and post-provider satisfaction, and pre- and post-knowledge. This was done 
using paired t tests. Stata 11.2 was used to analyze the data. Compliance to the 
protocol was measured by comparing the study year to the previous year in regard to 
“number of UDS’s ordered, number of chronic pain diagnoses on EMR problem lists, 
and the number of office visits with CNCP patients” (Canada et al., 2014, p. 4). 
Statistically significant findings were noted in all 3 practices with UDS orders increased 
by 145%. Practice 1 had the greatest improvement at 430% (p <  .05). Chronic pain 
diagnoses saw increases of 424% overall. Again, Practice 1 saw the greatest 
improvement at 918% {p < .05). Statistically significant improvements of attitudes 
were seen in multiple categories of the surveys. The knowledge portion of the survey
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for providers only saw a 15% increase (p <  .05). However, knowledge for staff did 
increase significantly.
Canada et al. (2014) discussed the implications of the study and stated,
“By increasing adherence to best practice standards, we believe this protocol will lead 
to improved management of patients with CNCP by providing objective urine data to 
guide a treatment plan, patient education with the CMA, and a documented evaluation 
and care plan” (p. 7).
Limitations of the study included educational background of practitioners, years 
of experience of practitioners, analysis of patient data on safety, abnormal lab results, 
and patient outcomes related to interventions. Canada et al. (2014) believed a more 
comprehensive study was warranted to determine better outcomes for patients and 
improve patient safety.
Initial development of patient-reported instruments. Jenkinson and Ravert 
(2013) conducted a quantitative and qualitative research citing that opioid abuse is a 
global issue affecting both industrialized and developing countries. This study found 
that 13.7% of patients admitted to misuse or abuse of opioid prescriptions by primary 
care providers at some point in their lifetime. Nurse practitioners (NPs) have become 
sole providers to underserved communities and give more health advice compared to 
physicians who write prescriptions without proper screening. Under current legislation 
laws in the U.S., NPs are prohibited from prescribing opioids which could help lessen 
the gap to increased opioid prescription writing.
Jenkinson and Ravert (2013) hypothesized one goal of office-based treatment of 
opiate dependence was to evaluate how providers stay compliant with the CDC’s latest
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guidelines for opioid prescribing. Understanding current guidelines, providers are now 
attempting to replace those who have an opioid addiction with methadone; however, the 
increasing problem continues to rise due to underutilized programs for proper guidance 
and treatment option, especially in rural areas.
According to Jenkinson and Ravert (2013), the CDC estimated billions were 
spent on costs associated with prescription opiate addiction (POA) in 2005 with an 
estimated rise since 2010. This escalation places opioid addiction second to marijuana 
use. Naloxone, an opioid antagonist, received Food and Drug Administration (FDA) 
approval to help curtail addiction in case of overdose. The efficacy has proven a 
successful outcome for those who were compliant. Extensive empirical evidence 
demonstrates that naloxone is safe and effective for treatment of opioid addiction in the 
primary care setting. Prescription opiate users usually have better outcomes with 
overuse because they come from a more stable environment and the addiction may not 
be as severe.
Weaknesses in this research, according to Jenkinson and Ravert (2013), 
indicated lack of experience or training by physicians was the most significant barrier. 
The next weakness was limited access to sufficient education or screenings prior to 
opioid initiation. Primary care physicians (PCP) face overcoming barriers that affect 
those who need treatment the most; however, nurse practitioners have legal authority to 
identify how they can control their chronic and harmful addiction.
Jenkinson and Ravert identified that office-based treatments were being unmet 
due to lack of screening for opioid addiction which causes potential problems to 
becoming addicted rather than being evaluated for treatment to help the addiction.
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According to Jenkinson and Ravert (2013), goals were not met with current system to 
monitoring monthly prescriptions for pain management or other symptoms.
Statistically, NPs deal with POA in primary care settings and have been providing 
excellent care with positive outcomes for patients who have a chronic problem. 
Jenkinson and Ravert (2013) indicated that NPs have received the highest patient 
satisfaction scores because they usually provide more health advice when compared to 
physicians to individuals who need the prescriptions but may be limited due to the 
awareness o f the rising problem.
Regional variance. Paulozzi, Mack, and Hockenberry (2012) presented 
findings to the CDC’s Morbidity and Mortality Weekly Report in July 4, 2014, which 
showed variation in prescription rates of opioids and benzodiazepines among states in 
the U.S. The study was conducted due to the prevalent, imminent threat of opioid 
misuse and overdose. As reported by the CDC in 2011, there were 16,917 deaths 
resultant of opioid overdose. Opioid-prescribing can present as a double-edged sword 
in that opioids are highly effective in treating pain, though highly addictive with 
potentially life-threatening side effects. Paulozzi et al. found that opioid pain relievers 
were more frequently prescribed among southeastern states. The study referenced other 
studies in which the former researchers could find no discernible explanation to the 
variance among states in opioid prescription. No theoretical framework was identified 
in the study. The study posed no hypothesis or research questions, though the purpose 
was clearly to determine variance among opioid prescribing practices among the states 
in America. The study also included benzodiazepine prescription rates; however, the 
current researchers focused solely on prescribing rates of opioids.
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The study collected data on prescribing in 2012 from IMS Health’s National 
Prescription Audit (NPA). The NPA provides estimates in each state by pooling 
opioids dispensed from retail pharmacies which accounts for approximately 80% of 
prescriptions in the U.S. The CDC then calculated prescribing rates per 100 persons for 
the U.S., each region, and each state. Paulozzi et al. (2012) found that prescribing rates 
were highest in Alabama, Tennessee, West Virginia, Kentucky, Oklahoma, and 
Mississippi, respectively. Paulozzi et al. found that prescribing rates were lowest in 
Hawaii, California, New York, Minnesota, New Jersey, and Alaska, respectively. The 
rates demonstrated a three- to fivefold variance from the highest to lowest states.
Paulozzi et al.’s (2012) study has strength and validity in demonstrating a 
difference among states in opioid prescription rates, though leaving a need for 
interpretation of the rationale for such difference. The researchers suggested that the 
gradient could not be explained by an underlying health disparity among the states— 
rather that it may be due to a lack of consensus among healthcare providers. Though 
several studies have found no correlation between regional health status and the rates of 
opioid prescription, it cannot be dismissed as a plausible explanation. Many of the 
regions with the highest rates of opioid prescription are known to have a greater 
prevalence of physical ailments linked to pain—most notably obesity.
Perhaps, the most definitive research to prove, disprove, or at least suggest a 
correlation between regional comorbidities and opioid prescription would be regional 
chart audits. Audits could aid in examination of the patient’s presentation and 
comorbidities as well as the provider’s adherence to guidelines in opioid prescription. 
Thus, this presents pertinence to the current research in which chart reviews were used
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to examine patient presentation and adherence to guidelines. According to data 
obtained in the current research, Mississippi has the 6th highest rate of opioid 
prescription.
Overdose education and naloxone prescription. Binswanger et al. (2015) 
conducted a study to investigate the use of naloxone distribution in the primary care 
setting. Binswanger et al. also delved into the beliefs and attitudes of those primary 
care providers about overdose and overdose education. The background of the study 
consisted of information regarding the unintentional overdose of opioid medications. 
The numbers of overdose have continually risen since the 1990s, but naloxone is an 
effective antagonist to these harmful side effects. Primary care providers represent a 
large number of providers able to educate patients regarding overdose and naloxone 
education. Binswanger et al. used the Theory of Planned Behavior and the Health 
Belief Model as theoretical frameworks for the study.
The study was conducted from August 2013 and October 2014 with 56 
participants taking part in 10 focus groups. Of the focus group participants, each group 
had at least one prescriber, such as a nurse practitioner, physician, or physician 
assistant. The goal of the study was to determine information in the following content 
areas: knowledge, barriers, benefits, and facilitators. The setting of the study took place 
in 3 large Colorado health systems that included family medicine, infectious 
disease/HIV practice, and primary care internal medicine. The results of focus groups 
were digitally recorded, and the results were used to analyze themes using both 
inductive and deductive analysis.
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Binswanger et al. (2015) chose to divide information into 4 content areas that 
included knowledge, barriers, benefits, and facilitators. The first content of knowledge 
found that most primary care providers did not have proper information of outpatient 
naloxone-prescribing, and many had not used the drug since their training days. The 
study also found that many of the providers were not aware if their patients had 
overdosed in the past. Binswanger et al. also stated that they were not knowledgeable 
enough about naloxone to feel comfortable about prescribing it to their patients. The 
results of the study identified several high-risk patient groups including those prescribed 
high-dose opioids or benzodiazepines, history of or predisposition of substance abuse 
disorders, or those with mental health disorders noted as the top 3 areas. The focus 
groups also identified barriers to the outpatient use of naloxone that included time 
consumption, difficulty in initiating conversations about overdose, lack of 
confidentiality with bystander training, patient cost and training, and the pharmacy 
availability of naloxone to the patient and pharmacy.
The benefit that was identified through this study by Binswanger et al. (2015) 
was the decrease of death with naloxone use. Binswanger et al. also identified areas 
that would need to be set up prior to implementing the use of naloxone, such as protocol 
for prescribing and plans for what to do after the administration of naloxone in the 
outpatient setting. Future research included in the study suggested that research needs 
to be implemented for patient satisfaction with the idea of naloxone administration. 
Future research also should determine if naloxone promotes risk compensation. 
Binswanger et al. (2015) also discussed the need to research the true effectiveness of 




The purpose of this study was to determine if primary care providers in 
Mississippi were compliant with the CDC’s latest guidelines for opioid prescribing. 
Opioid overdose deaths have increased exponentially in recent years, and opioid 
prescribing practices have become a growing area of concern (Doyon et al., 2014). 
Mississippi has very high opioid prescribing rates, when compared to the national 
average (MSDH, 2016). Therefore, the student researchers examined opioid- 
prescribing practices in Mississippi to determine the most recent guideline adherence 
rates. This body of research first focused specifically on 3 key elements of the current 
CDC guidelines: (a) prescribing nonopioid treatments first, (b) avoiding concurrent 
prescribing of opioids and benzodiazepines, and (c) checking urine drug screens prior to 
opioid initiation and then annually. The secondary focus of the research was 
determining whether PCPs in Mississippi were prescribing naloxone for opioid 
overdose reversal, as recent research has shown naloxone to be highly effective as a 
life-saving treatment for opioid overdose (Wheeler et al., 2015). Finally, the 
researchers examined whether PCPs in Mississippi provided sufficient patient education 
related to opioids. The student researchers assumed that, through patient education, 
adherence to CDC guidelines, and naloxone prescribing, patients would have reduced 
risk of opioid overdose and misuse.
Design of the Study
A nonexperimental, quantitative, descriptive, retrospective review of charts in 6 
primary care clinics in the southeastern United States was conducted to evaluate
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adherence to the CDC guidelines of opioid-prescribing by primary care providers. A 
convenience sampling of 600 charts for retrospective chart review was conducted. All 
chart reviews were conducted within each clinic; no charts were removed from the 
clinics for the purpose of this study. This design type was beneficial due to the 
accessibility of charts for review, limited time to obtain data, and the ability to preserve 
anonymity of the individual patient.
Setting for the Research Project
The setting for the research project was primary care clinics in the southeastern 
region of the U.S. More specifically, the student researchers collected data from 6 
clinics in Mississippi staffed by physicians and nurse practitioners. The clinics were in 
the following regions: east central, west central, and northeast Mississippi.
Population and Sample
The population considered for this study included men and women above the 
age of 18 years, o f all ethnicities and socioeconomic statuses, and formally diagnosed 
with chronic pain. Inclusion criteria were as follows: (a) age 18 years or older, (b) 
medically treated chronically with opioids (defined as 2 or more opioid prescriptions 
written >21 days apart) for CNCP, and (c) prescribed by a PCP (physician or nurse 
practitioner). Oncology patients, except non-melanoma skin cancer and prostate cancer 
patients, were excluded from the study. A random convenience sampling of 600 
medical records was selected for the purposes of chart review in this study. The chart 
selection included the ICD-10 diagnosis codes G89.2 chronic pain (not elsewhere 
classified), G89.21 chronic pain due to trauma, G89.22 chronic post-thoracotomy pain, 
G89.28 other chronic post-procedural pain, G89.29 other chronic pain, G89.4 chronic
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pain syndrome, R52 pain unspecified, M25.5 pain in joint, M25.50 pain in unspecified 
joint, M25.51 pain in shoulder, M25.52 pain in elbow, M25.53 pain in wrist, M25.54 
pain in joints of hand, M25.55 pain in hip, M25.56 pain in knee, M25.57 pain in ankle 
and joints of foot, M54.2 cervicalgia, M54.9 dorsalgia, M54.5 low back pain, M54.6 
pain in thoracic spine, M79.60 pain in limb, M79.62 pain in upper arm, M79.63 pain in 
forearm, M79.64 pain in hand and fingers, M79.65 pain in thigh, M79.66 pain in lower 
leg, or M79.67 pain in foot and toes. For this research, 6 primary care clinics were 
chosen; 100 charts were reviewed from each of the clinics. The clinics are in rural areas 
as well as some more urban settings of Mississippi. Site A is an internal medicine clinic 
with a single MD provider treating adults only for acute and chronic illnesses. Site B is 
a family medical clinic which employs 3 providers (1 MD and 2 NPs). This clinic treats 
patients from 4 months and older. Site C is a federally-funded facility with 2 MDs, 3 
FNPs, 1 PNP, and 1 DMD. This site treats patients from birth throughout the lifespan. 
Site D is a family medical clinic with 1 MD and 3 NPs. This facility treats patients 
from age 2 months and older, acute and chronic illnesses, and women’s health. Site E is 
a combination family practice and urgent care clinic with 1 MD who treats acute and 
chronic illnesses from age 6 months and older. Site F is a regional health system 
employing 14 MDs, 7 DOs, and 2 NPs. This site treats adults for acute and chronic 
illnesses.
Clerical staff from each primary clinic pulled charts that were specific to the 
criteria for this study. From those, 100 charts were chosen for review per researcher. 
Each chart was reviewed using a data collection worksheet to determine prescribing 
practices with regard to opioids. These charts were reviewed in a legal and ethical
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manner, with no interaction with patients. The charts were reviewed using the latest 
CDC guidelines for opioid-prescribing in Mississippi.
Methods of Data Collection
Prior to conducting the study, consent was obtained from the Institutional 
Review Board (IRB) at the Mississippi University for Women (see Appendix A). After 
consent from the IRB was obtained, each research team member contacted his or her 
respective clinic manager and obtained consent to perform a chart review to obtain data 
(see Appendix B). Each member reviewed the charts pulled by office staff in a random 
convenience sample of 100 charts. The Opioid and Naloxone Prescribing Practices 
Data Collection Worksheet was utilized by each member to collect the data (see 
Appendix C). Once the data collection was completed, each researcher compiled their 
respective data into a single word processing spreadsheet. These data were stored on a 
password-protected USB drive. There was no patient interaction for data collection. 
Methods of Data Analysis
The collected data were compiled into a word processing document. These data 
were then analyzed to determine if primary care providers were adhering to the CDC’s 
guidelines for administration of opioid pain medications and if they were prescribing 
Narcan for patients who were prescribed opioid pain medications for patients 18 years 
of age or older with chronic, non-cancer pain. After data collection, the data were 





Drug overdoses have increased in the last 3 decades in the U.S. (Doyon et al., 
2014). The purpose of this study was to determine if primary care providers in 
Mississippi are compliant with the CDC’s latest guidelines for opioid prescribing. The 
student researchers examined opioid-prescribing practices in Mississippi to determine 
the rates of adherence to the guidelines. The primary focus of this research was 3 key 
elements of the current CDC guidelines: (a) prescribing nonopioid treatments first, (b) 
avoiding concurrent prescribing of opioids and benzodiazepines, and (c) checking urine 
drug screenings prior to opioid initiation and then annually. The secondary focus of the 
research was determining whether PCPs in Mississippi were prescribing naloxone for 
opioid overdose reversal as recent research has shown naloxone to be highly effective 
as a life-saving treatment for opioid overdose (Wheeler et al., 2015). Finally, the 
researchers examined whether PCPs in Mississippi provided patient education related to 
opioids and overdose. Nonexperimental, quantitative, descriptive, retrospective review 
of charts in 6 primary care clinics in the southeastern United States was conducted to 
evaluate adherence to the CDC guidelines of opioid-prescribing by primary care 
providers.
A convenience sampling of 600 charts was conducted by performing a 
retrospective chart review. The Opioid and Naloxone Prescribing Practices Data 
Collection Worksheet was utilized by each member to collect the data. This chapter 
describes the study’s sample. This chapter also answers the research questions by
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applying the findings from the study and discusses the profile of study participants. 
Statistical results are summarized in figures.
Profile of Study Participants
Data for the research study were collected by method of convenience sampling. 
A retrospective chart review was performed on 100 charts from 6 clinics in the 
southeastern United States. Each researcher drew their sample from a different clinical 
site. The sample included patients 18 years or older with an active diagnosis of chronic, 
non-cancer pain. Cancer patients, with the exception of non-melanoma skin cancer and 
prostate cancer, were excluded from the sample. Acute pain was also excluded from the 
sample. The sample was used to examine provider adherence to the most recent CDC 
Guidelines for Opioid Prescribing.
If treatment was initiated before the guidelines were released, the following 
categories were marked as not applicable'. Nonpharmacologic therapy initiated prior to 
opioids, nonopioid therapy initiated prior to opioids, and urine drug screen performed 
prior to initiation of opioids. If there was clear documentation of these criteria being 
met, however, it was included in the findings. The selected charts represent patients 
that were 18 years and older with an active diagnosis of chronic, non-cancer pain. The 
selection was made after the CDC guidelines were published in March of 2016; 
therefore, the sample population only included patients treated from March 2016 
through May 2017. At each clinical site, a random convenience sampling of 100 
medical records was selected for the purposes of chart review in this study. Five of 6 
clinical sites utilized EMRs, while one clinic still utilized paper charting. The EMRs 
were selected by searching for the ICD-10 criteria. The paper charts were chosen by
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random selection of charts until 100 pain patients were identified. The chart selection 
included the following ICD-10 pain diagnoses: G89.2 chronic pain not elsewhere 
classified, G89.21 chronic pain due to trauma, G89.22 chronic post-thoracotomy pain, 
G89.28 other chronic post-procedural pain, G89.4 chronic pain syndrome, R52 pain 
unspecified, M54.5 low back pain, M54.6 pain in thoracic spine, or G89.29 other 
chronic pain. Demographic information extracted included age and gender. Other 
information documented from the charts included provider type and ICD-10 pain 
diagnoses.
Age. The research sample consisted of individuals ranging in age from 25 years 
to 94 years old.
Gender. The sample population was comprised of more females than males. 
The gender distribution was 45% male {n = 267) and 55% female (/? = 332). Figure 1 







Figure 1. Percentage of gender distribution in the sample population.
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Provider type. The researchers determined the type of prescribing provider 
while collecting their data. Of the sample population, 65% of providers were Doctors 
of Medicine (/? = 388), 29% were Nurse Practitioners (n = 177), and 6% were Doctors 
of Osteopathic Medicine (n = 34). Figure 2 represents the distribution of provider types 
amongst the sample population.
Provider Type
Figure 2. Percentages of opioid-prescribing providers.
Statistical Results
A random convenience sampling of 600 medical records were reviewed to 
complete this retrospective chart review. Inclusion criteria were as follows: (a) age 18 
years or older, (b) medically treated long-term with opioids (defined as 2 or more opioid 
prescriptions written > 21 days apart) for chronic non-cancer pain, and (c) prescribed by 
a PCP (physician or nurse practitioner). The Opioid and Naloxone Prescribing 
Practices Data Collection Worksheet was utilized by each member to collect the data.
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The researchers entered all statistical information from the data collection worksheets 
into a Microsoft Excel spreadsheet and formulated to determine n = number for each 
category. The researchers investigated the following research questions:
1. Are primary care providers in Mississippi compliant with the following 
selection of the CDC’s latest guidelines for prescribing opioids for chronic 
pain in Mississippi?
a. Nonpharmacologic therapy or nonopioid pharmacologic therapy first.
b. Avoid concurrent prescribing of opioids and benzodiazepines.
c. Check urine drug screen prior to opioid initiation and then annually.
2. Are primary care providers in Mississippi prescribing naloxone for opioid 
overdose reversal?
3. Do primary care providers provide education to patients regarding opioid 
overdose?
Research question 1. Are primary care providers in Mississippi compliant with 
the following selection of the CDC’s latest guidelines for prescribing opioids for 
chronic pain in Mississippi?
a. Nonpharmacologic therapy or nonopioldpharmacologic therapy first. The 
researchers determined if primary care providers used nonpharmacologic therapy or 
nonopioid pharmacologic therapy before prescribing opioids. After performing a 
random convenience sampling of 600 medical records, the researchers found the 
following: O f the 600 charts reviewed, 9% o f the patients were prescribed 
nonpharmacologic therapy first (/? = 54), 12% of the patients were not prescribed 
nonpharmacologic therapy first (/? = 70), and 79% of the selected charts were classified
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as not available (n = 475), as initiation of therapy was prior to initiation of the CDC 
guidelines. O f the 600 charts reviewed, 26% of the patients used nonopioid therapy 
first (n = 156), 14% of the patients did not use nonopioid therapy first (n = 84), and in 
60% of the selected charts this information was not available (n = 360).
b. Avoid concurrent prescribing o f opioids and benzodiazepines. The 
researchers determined if primary care providers avoided concurrent prescribing of 
opioids and benzodiazepines. After performing a random convenience sampling of 600 
medical records, the researchers found the following: O f the 600 charts reviewed, 20% 
of the patients were prescribed opioids and benzodiazepines concurrently {n = 120) and 
80% of the patients were not prescribed opioids and benzodiazepines concurrently {n = 
479).
c. Check urine drug screen prior to opioid initiation and then annually. The 
researchers determined if primary care providers checked a urine drug screen prior to 
opioid initiation and annually. After performing a random convenience sampling of 
600 medical records, the researchers found the following: O f the 600 charts reviewed, 
20% of the patients had urine drug screens (n = 120) and 80% of the patients did not 
















Figure 4. Percentage of patients prescribed nonopioid therapy first.
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Concurrent Benzodiazepines
Figure 5. Percentages of patients concurrently prescribed opioids and 
benzodiazepines.
Urine Drug Screen
Figure 6. Percentages of patients with urine drug screens prior to opioid 
initiation and then annually.
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Research question 2. Are primary care providers in Mississippi prescribing 
naloxone for opioid overdose reversal? The researchers determined if primary care 
providers prescribed naloxone therapy for opioid overdose reversal when prescribing 
opioids. After performing a random convenience sampling of 600 medical records, the 
researchers found the following: Of the 600 charts reviewed, 0% of the patients were 
prescribed naloxone therapy (n = 0) (see Figure 7).
Naloxone Prescribed
100%
Figure 7. Percentage of patients that received naloxone therapy.
Research question 3. Do primary care providers provide education to patients 
regarding opioid overdose? The researchers determined if primary care providers gave 
education regarding opioid overdose before prescribing opioids. After performing a 
random convenience sampling of 600 medical records, the researchers found the 
following of the 600 charts reviewed: 48% of those patients did receive education
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regarding opioid overdose (n = 286) and 52% did not receive education regarding 
opioid overdose (/? = 314) (see Figure 8).
Opioid Education Provided
Figure 8. Percentages of patients who were educated about opioid overdose.
Summary of Findings
Chapter IV presented the researchers’ findings from the retrospective review of 
600 patients from 6 clinics in the southeastern United States. Findings from the 
demographics and research questions were presented in figures. The results of this 
analysis revealed noncompliance among primary care providers regarding the 
prescription of nonpharmacologic and nonopioid therapy first. The results also revealed 
that most primary care providers did avoid concurrent prescribing of opioids and 
benzodiazepines, and most of the primary care providers were noncompliant with urine 
drug screens prior to opioid initiation and annually. Furthermore, primary care 
providers in the selected clinics did not prescribe naloxone for opioid overdose reversal. 
Finally, the results revealed that < 50% of the patients received education regarding 
opioid overdose. These conclusions highlight the opportunity for improvement among
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primary care providers, especially nurse practitioners, regarding opioid prescribing 
practices. Figure 9 represents the overall adherence to CDC guidelines and naloxone 
prescribing practices per individual guideline.
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Figure 9. Summary of reviewed charts in compliance with CDC opioid-prescribing 




The study determined whether the selected primary care providers were 
following CDC guidelines for prescribing opioids and whether providers were 
prescribing naloxone for opioid overdose reversal. The study also sought to determine 
if the selected primary care providers were providing education regarding the risks of 
opioids, as well as education about naloxone, if prescribed. Hydrocodone and 
oxycodone continue to be the most numerous prescriptions written according to the 
MSDH in 2016, and they continue to be the leading cause of unintended overdoses and 
death of many individuals. Many of the overdoses are not only resulting from opioids 
smuggled into the country, but additionally as a result of indiscriminate opioid 
prescribing by healthcare providers.
The research project allowed knowledge expansion of opioid overdose and 
providers’ prescribing habits. The research group formulated questions based on the 
CDC guidelines for treatment of chronic, non-cancer pain which were published in 
March of 2016. The purpose of the research project was to determine compliance with 
the selected guidelines. The secondary goal was to determine the need for increased 
education among providers regarding opioid treatment of chronic, non-cancer pain. 
Compliance was evaluated by the following research questions:
1. Are primary care providers in Mississippi compliant with the following 
selection of the CDC’s latest guidelines for prescribing opioids for 
chronic pain in Mississippi?
a. Nonpharmacologic therapy or nonopioid pharmacologic therapy first.
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b. Avoid concurrent prescribing of opioids and benzodiazepines.
c. Check urine drug screen prior to opioid initiation and then annually.
2. Are primary care providers in Mississippi prescribing naloxone for opioid 
overdose reversal?
3. Do primary care providers provide education to patients regarding opioid 
overdose?
The research was guided by previous studies related to the opioid epidemic. An 
overview of the literature review is as follows. According to Venes (2013), chronic 
pain is the leading cause of disability. Harle et al. (2015) found that a lack of pain 
specialists has resulted in the need for primary care providers to manage chronic pain 
although effective management is often challenging. Wolfe et al. (2016), in reference to 
the CDC, found that too many physicians are prescribing opioids without trying other 
methods first. Canada et al. (2014) developed and implemented a new EMR-based 
protocol to improve opioid prescribing practices. Canada et al. determined their EMR- 
based protocol increased adherence to best practice standards and led to safer and more 
effective management of chronic, non-cancer pain (Canada et al., 2014). Finally, 
according to Jenkinson and Ravert, naloxone has been approved by the FDA for use in 
the primary care setting. These previous studies established a foundation to guide the 
principles of this study.
A random convenience sampling of 600 medical records were reviewed to 
complete this retrospective chart review. Inclusion criteria were as follows: (a) age 18 
years or older, (b) medically treated long-term with opioids (defined as 2 or more opioid 
prescriptions written > 21 days apart) for chronic non-cancer pain, and (c) prescribed by
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a PCP (physician or nurse practitioner). Data were collected and analyzed in the results 
section and will be discussed in the following sections: Summary and Discussion of the 
Findings, Conclusions, Implications, Limitations, and Recommendations.
Summary of the Findings
The sample project consisted of 600 participants. The participants received care 
at 6 primary care clinics in the southeastern United States between March 2016 and 
May 2017. The sample consisted of 45% (/? = 267) males and 55% (n = 332) females. 
The age ranges were from 25-94 years. O f the charts reviewed, 0% of the patients were 
prescribed naloxone therapy (n = 0) for emergent opioid overdose reversal. Of the 
charts reviewed, 48% of the patients received education regarding opioid overdose (n = 
286) and 52% did not receive education regarding opioid overdose (n =314). O f the 
charts reviewed, 9% of the patients utilized nonpharmacologic therapy first (n  = 54), 
12% of the patients were not treated by nonpharmacologic therapy first (n = 70), and in 
79% of the selected charts, this information was not applicable (n = 475). Of the charts 
reviewed, 26% of the patients used nonopioid therapy first (n = 156), 14% of the 
patients did not use nonopioid therapy first (n = 84), and in 60% of the selected charts, 
this information was not applicable {n = 360). O f the charts reviewed, 20% of the 
patients were prescribed opioids and benzodiazepines concurrently (n = 121) and 80% 
of the patients were not prescribed opioids and benzodiazepines concurrently (n = 479). 
O f the charts reviewed, 20% of the patients had urine drug screens (n = 120), and 80% 
of the patients did not have urine drug screens (n = 479). O f the sample population (n = 
600), 65% of providers were Doctors o f Medicine (n = 388), 29% were Nurse
62
Practitioners (n = 177), and 6% were Doctors of Osteopathic Medicine (n = 34) o f the 
sample population.
Discussion of the Findings
Many of the charts reviewed were of patients who were prescribed opioid 
therapy for chronic, non-cancer pain prior to the March 2016 publication of the CDC 
guidelines for prescribing opioids for chronic pain, thus data prior to the date of 
publication were excluded from the study. Since prior data were excluded, it cannot be 
determined if the patient was treated with nonpharmacologic and/or nonopioid therapy 
prior to initiation of opioid therapy; in these instances, findings were labeled as not 
applicable. Approximately 43% of the applicable 178 charts reviewed were prescribed 
nonpharmacologic therapy prior to opioid therapy {n = 54). Of the 396 applicable 
charts reviewed, 65% were prescribed nonopioid therapy prior to opioid therapy (/? = 
156). O f the 600 charts reviewed, 20% of patients were prescribed opioids and 
benzodiazepines concurrently (/? = 120). Of the 600 charts reviewed, 20% of patients 
had a drug screen in compliance with the CDC guidelines, i.e. a drug screen prior to 
opioid treatment and an annual drug screen thereafter (n = 120). The researchers found 
that of the 600 charts reviewed, none of the patients received naloxone therapy {n = 0). 
This is most likely due the cost of prescription naloxone. The cost of a naloxone auto­
injector ranges from $2,250 to $2,460 out-of-pocket and coverage varies among health 
insurance companies. However, this may also be attributed to common practice, as well 
as the fear that prescribing naloxone will lead to more risky use of opioids by patients. 
The researchers found that 48% of the charts reviewed received education regarding the 
risks of opioids {n = 288).
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A random, convenience sampling of 600 medical records were reviewed. The 
sample population was comprised of more females than males. The gender distribution 
was 45% male (/? = 267) and 55% female {n = 332). There was no statistical 
significance between gender and opioid-prescribing practices. Of the sample 
population, 388 of providers were Doctors of Medicine, 177 were Nurse Practitioners, 
and 34 were Doctors of Osteopathic Medicine. There was no statistically significant 
effect on prescribing practices between the 3 provider types evaluated.
Conclusions
The purpose of this study was to determine if primary care providers in 
Mississippi were treating chronic, non-cancer pain in accordance with the CDC 
guidelines for prescribing opioids. The study evaluated the charts of patients 18 years 
of age or older. The study design was a retrospective chart review of 600 charts that 
were selected based on applicable chronic pain diagnoses in patients treated with 
opioids. The most recent CDC guidelines were published in March 2016, and all data 
prior to that date were excluded from the study. Based on the research data, the 
majority of primary care providers in Mississippi were not consistently following CDC 
guidelines for opioid prescribing. The data were collected within the first year after the 
2016 CDC guidelines were published, so it is plausible that the primary care providers 
were unaware of the changes in approach to managing chronic, non-cancer pain. 
However, it should be noted that ignorance is not accepted by governing bodies, such as 
the Board of Medicine, the Board of Nursing, and the Drug Enforcement Agency 
(DEA). The researchers concluded that primary care providers in Mississippi
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demonstrate a need for heightened awareness and education regarding the CDC’s 
guidelines for opioid-preseribing.
Implications
The incidence of opioid-related overdose and death has continuously risen to 
unprecedented levels, which led to the investigation of the epidemiology of the 
aforementioned trend. The problem has gained attention of multiple federal and state 
agencies, such as the DEA and the CDC. In March of 2016, the CDC released new 
guidelines by which healthcare providers should approach chronic, non-cancer pain 
management. The guidelines have been accepted as best practice by both the Board of 
Medicine and the Board of Nursing. While the new guidelines are not rule, regulation, 
or law, prudent medical judgment should be carefully considered when prescribing 
outside the CDC recommended criteria. As the CDC guidelines continue to be 
disseminated, healthcare providers are still finding themselves in the crosshairs of legal 
fire for failure to adhere to certain guidelines. Some states are enacting new stricter 
prescribing laws that align with the CDC guidelines in an effort to curb the opioid crisis. 
As the CDC guidelines continue to be disseminated, it is advised that healthcare 
providers should practice in compliance with the CDC guidelines for management of 
chronic, non-cancer pain.
This research project yielded findings that are ineongruent with evidence-based 
best practice as outlined in the CDC Guidelines for Opioid Prescribing. The 
implications are that nonadherence continues to place patients at risk. Furthermore, 
nonadherent healthcare providers are at risk of losing their credentials and licensure. 
These providers are also at risk for financial penalties and potentially criminal charges.
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Nola Pender’s HPM should serve as a standard that nurse practitioners use in treating 
chronic, non-cancer pain. The evidence demonstrates the risks associated with 
nonadherence to the CDC guidelines. The CDC guidelines are evidence-based and 
congruent with the HPM. The HPM is designed to promote health through prevention 
and promotion of health-conscious behaviors. Nola Pender described nursing as “the 
science and art of helping people change their lifestyle to move toward a state of 
optimal health” (Alligood, 2014, p. 303). Thus, the goal of the nurse practitioner, as 
well as other healthcare providers, is to promote optimal health by recognizing the risks 
of opioids and utilizing best practice in regard to managing chronic, non-cancer pain as 
outlined by the CDC.
Limitations
Limitations readily identifiable prior to performing data collection were 
identified as small sample size, geographically limited data collection, and the use of 
convenience sampling. As recognized in the methodology section of this study, data 
were obtained by performing a retrospective chart review from 6 primary care clinics in 
Mississippi. The population ranged from central and east central Mississippi to north 
Mississippi. Data were collected and analyzed from a sample of 600 charts. The study 
was designed to examine the opioid and naloxone prescribing practices o f primary care 
providers.
The sample size of 600 charts was relatively small and potentially decreased the 
reliability of generalizing to the entire populous. The study could be replicated to 
obtain a larger sample size. The larger sample would most likely represent the actual
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trend in prescribing practices. Obtaining information from a larger sample consisting of 
multiple states across the nation would also be beneficial.
The study was geographically limited and unlikely represented prescribing 
practices across the nation. A similar study was conducted in which the findings 
suggested a threefold to fivefold variance among states in the U.S. in rates of opioid- 
prescribing (Paulozzi et al., 2014). Paulozzi et al. (2014) found that Mississippi had the 
6th highest opioid prescription rates; this was the trend among multiple southeastern 
states.
The final limitation known prior to data collection was the use of convenience 
sampling. As it pertains to research, convenience sampling is the weakest form of 
sampling. Convenience sampling is often a beginning point to lead to further research. 
In this study, data were obtained from a random sample of charts. This method may not 
represent the entire population of the clinic nor is it likely to provide strong assumptions 
o f other clinics. However, the method of chart review may be stronger than data 
obtained by volunteers.
During data collection and analysis, the researchers recognized that many of the 
populations sampled were established chronic, non-cancer patients that began treatment 
prior to the implementation of the CDC guidelines in March 2016. Therefore, several 
parameters could not be analyzed and were marked as not applicable. Those 
nonapplicable parameters were identified as implementation of nonpharmacologic and 
nonopioid therapy prior to opioid initiation as well as an initial urine drug screen. 
Furthermore, the study may have yielded skewed results due to the relatively short 
timeframe between data collection and dissemination of the new guidelines.
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Recommendations
The researchers recommend that this study be replicated with a larger population 
throughout multiple regions in the United States. The researchers also recommend that 
the study be replieated annually to determine if there was an increase in adherence to 
the CDC guidelines. The timeframe for a newly established guideline to be 
implemented into common practice is typically 2 years. This amount of time should 
pass before replicating the study. Therefore, the spring of 2018 would be an appropriate 
delay before a new set o f data could be obtained to analyze. This particular research 
design could be replicated exactly to determine if there was increased adherence in the 
same region. Any future study should also evaluate if an increase in naloxone 
prescription occurs. The researchers recommend correlating adherence to the 
guidelines with the incidence of opioid-related overdose and deaths.
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College ck Nursing and Speech Language Pathology
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Columbus, Mississippi 39701-5800
Dear Dr. McCarter:
I am pleased to inform you that the members of the Institutional Review Board (IRB) 
have reviewed the following proposed research and have approved it as submitted:
Name of Study: Opioid and Naloxone Prescribing Practices in
Mississippi
lnvestigat<or(s): Rebecca Brown, Brittany Clayton, Alissa Damiens,
Natalie Keyes, Gary Adam McPherson, and Anna 
Elizabeth Vriygul 
Research Facultji/Advison Carey McCarter
I wish you much success in your research.
Sincerely,
Thomas C. Richardson, Ph.D.
Provost and Vice President for Academic Affairs
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SUBJECT : Permission to Participate in a Quality Assurance Research Study
We are graduate students at Mississippi University for Women in the Family Nurse 
Practitioner program in Columbus, MS. As a program requirement, we are conducting 
a retrospective chart review to assess primary care provider compliance to opioid 
prescription guidelines set forth by the Centers for Disease Control and Prevention 
(CDC). The students that are participating in this research project are Rebecca Brown, 
Brittany Clayton, Alissa Damiens, Natalie Keyes, Gary Adam McPherson, and Anna 
Elizabeth Wiygul.
We are requesting your permission to utilize your clinic as one of the settings for our 
study. By providing us with permission, we will have access to your patients’ medical 
records for a retrospective chart review. We recognize the essential need for 
confidentiality in regard to patient health information. Each student has completed a 
HIPAA training workshop through Mississippi University for Women. The students 
further agree to protect all information obtained, and no identifying information will be 
recorded. We will be utilizing a student-designed data collection worksheet to collect 
the required information. A copy of this tool is included with this letter. We will 
transcribe the data directly from the chart to the data collection form, thus no patient 
identifiers will be removed from the clinic. No identifying personal, provider, or clinic 
information will be included. A complimentary copy of the study results will be 
provided to all participating clinics.
If you have any questions concerning this research study, please call Rebecca Brown 
(601-826-5200), Brittany Clayton (662-397-1159), Alissa Damiens (662-571-2911), 
Natalie Keyes (601-966-3416), Gary Adam McPherson (601-938-1599), Anna 
Elizabeth Wiygul (662-574-4774) or you may contact the chair of our research 
committee, Carey McCarter, DNP, FNP-BC (662-295-1858). Your participation in this 
study is strictly voluntary. The amount of time required for us to review charts and 
collect data will be approximately one month. In addition, you may withdraw your 
consent and participation in this study at any time by contacting one of us or the chair of 
our research committee.
Sincerely,
Rebecca Brown, Brittany Clayton, Alissa Damiens, Natalie Keyes, Gary Adam 
McPherson, and Anna Elizabeth Wiygul
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Was non pharmacologic therapy initiated before nonopioid therapy?
 a. No
______ b. Yes
Was nonopioid pharmacologic therapy initiated before opioid therapy?
 a. No
______ b. Yes
Concurrent prescribing of opioids and benzodiazepines?
 a. No
______ b. Yes
Urine drug screen prior to opioid initiation?
 a. No
______ b. Yes
Was naloxone prescribed with the prescribed opioid?
______ a. No
______ b. Yes
Was education provided for overdose prevention and overdose awareness?
 a. No
______ b. Yes
Pain related ICD 10__________
Provider’s Type
 a. NP
 b. MD
 c. D.O.
d. PA
